Perspective Therapeutics (CATX) EBT Margin (2010 - 2023)
Perspective Therapeutics recorded quarterly EBT Margin of 158.57% in Q4 2023, up 133.46% quarter-over-quarter from 473.96% in Q3 2023.
Perspective Therapeutics' EBT Margin history runs 14 years deep, the most recent figure standing at 158.57% for Q4 2023.
- In Q4 2023, EBT Margin changed N/A year-over-year to 158.57%; the TTM figure through Dec 2023 stood at 6542.58% (changed N/A YoY), while the FY2023 annual figure was 2796.79%, changed N/A from the prior year.
- EBT Margin came in at 158.57% for Q4 2023 at Perspective Therapeutics, up from 473.96% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 158.57% in Q4 2023 to a low of 740.4% in Q2 2023.
- A 5-year average of 129.93% and a median of 52.13% in 2020 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin surged 10180 bps in 2021 and slumped 65745 bps in 2023, its largest moves.
- Perspective Therapeutics' EBT Margin stood at 40.66% in 2019, then advanced by 10 bps to 36.8% in 2020, then slumped by 55 bps to 56.96% in 2021, then tumbled by 316 bps to 236.92% in 2022, then soared by 167 bps to 158.57% in 2023.
- According to Business Quant data, EBT Margin over the past three periods registered 158.57%, 473.96%, and 740.4% for Q4 2023, Q3 2023, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.17% |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 158.57% |
| Sep 30, 2023 | -473.96% |
| Jun 30, 2023 | -740.40% |
| Mar 31, 2023 | -594.04% |
| Sep 30, 2022 | -236.92% |
| Jun 30, 2022 | -82.95% |
| Mar 31, 2022 | -46.29% |
| Dec 31, 2021 | -56.96% |
| Sep 30, 2021 | -87.48% |
| Jun 30, 2021 | 49.67% |
| Mar 31, 2021 | -28.65% |
| Dec 31, 2020 | -36.80% |
| Sep 30, 2020 | -29.91% |
| Jun 30, 2020 | -52.13% |
| Mar 31, 2020 | -18.92% |
| Dec 31, 2019 | -40.66% |
| Sep 30, 2019 | -35.25% |
| Jun 30, 2019 | -56.91% |
| Mar 31, 2019 | -58.68% |
| Dec 31, 2018 | -74.26% |
| Sep 30, 2018 | -96.54% |
| Jun 30, 2018 | -147.10% |
| Mar 31, 2018 | -84.68% |
| Dec 31, 2017 | -95.25% |
| Sep 30, 2017 | -127.66% |
| Jun 30, 2017 | -133.94% |
| Mar 31, 2017 | -106.08% |
| Dec 31, 2016 | -141.05% |
| Sep 30, 2016 | -142.92% |
| Jun 30, 2016 | -107.33% |
| Mar 31, 2016 | -106.26% |
| Dec 31, 2015 | -113.88% |
| Sep 30, 2015 | -82.15% |
| Jun 30, 2015 | -77.12% |
| Mar 31, 2015 | -84.81% |
| Dec 31, 2014 | -88.96% |
| Sep 30, 2014 | -104.78% |
| Jun 30, 2014 | -137.93% |
| Mar 31, 2014 | -87.14% |
| Dec 31, 2013 | -96.18% |
| Sep 30, 2013 | -117.62% |
| Jun 30, 2013 | -82.17% |
| Mar 31, 2013 | -65.85% |
| Dec 31, 2012 | -112.70% |
| Sep 30, 2012 | -106.29% |
| Jun 30, 2012 | -75.92% |
| Mar 31, 2012 | -58.14% |
| Dec 31, 2011 | -64.68% |
| Sep 30, 2011 | -90.84% |
| Jun 30, 2011 | -62.81% |
| Mar 31, 2011 | -61.48% |
| Dec 31, 2010 | -52.06% |
| Sep 30, 2010 | -65.70% |